Procurement Summary
Country: Ukraine
Summary: Ondansetron Solution for Injection 2 Mg/Ml in 4 Ml; Ondansetron Solution for Injection 2 Mg/Ml in 2 Ml; Tranexamic Acid Solution for Injection, 50 Mg/Ml in 5 Ml; Magnesium Sulfate, Solution for Injection, 250...
Deadline: 26 Jan 2026
Posting Date: 23 Jan 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 134184632
Document Ref. No.: UA-2026-01-21-015674-a
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 12697065
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Ondansetron solution for injection 2 mg/ml in 4 ml; Ondansetron solution for injection 2 mg/ml in 2 ml; Tranexamic acid solution for injection, 50 mg/ml in 5 ml; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Glucose solution for injections 40% in 20 ml; Theophylline solution for injection 20 mg/ml in 5 ml; Omeprazole 40 mg bottle; Metoclopramide, solution for injection, 5 mg/ml, 2 ml each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Atropine sulfate solution for injection 1 mg/1 ml, in ampoule 1 ml; Amiodarone, solution for injection, 50 mg/ml, 3 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Torasemide, solution for injection, 5 mg/ml, 4 ml each; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Isosorbide, concentrate/solution, 1 mg/ml, 10 ml each; Haloperidol, solution for injection, 5 mg/ml, 1 ml each; Nadroparin, solution for injection, 9500 IU anti-Xa/ml, 0.3 ml each; Nadroparin, solution for injection, 9500 IU anti-Xa/ml, 0.6 ml each; Enoxaparin sodium, solution for injection, 10, 000 anti-Xa IU/ml, 0.4 ml each; Enoxaparin sodium, solution for injection, 10, 000 anti-Xa IU/ml, 0.2 ml each; Enoxaparin sodium, solution for injection, 10, 000 anti-Xa IU/ml, 0.8 ml each; Sodium heparin, solution for injection, 5000 IU/ml, 5 ml each; Dexamethasone, solution for injection 4mg/ml; lidocaine, solution for injections, 100 mg/ml, 2 ml each; Lidocaine, solution for injection, 20 mg/ml, 2 ml each; Human insulin (Medium duration of action), suspension for injections, 100 U/ml, bottle, 10 ml each; Human insulin (Combination: 30% Short tri... Type of purchase: products Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Ondansetron solution for injections 2 mg/ml in 4 ml; Filgrastim, solution (48 million IU), 0.8 ml each Classification according to INN: Filgrastim, Classification according to ATX: L03AA02, Release form: Solution for injection or infusion, Packaging type: Pre-...
Documents
Tender Notice